Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2019 | Story Xolisa Mnukwa
Esihle Mhluzi
“As a small-town girl from the Eastern Cape, the only thing I have ever inculcated within myself was the validity of my dreams.” – Esihle Mhluzi #WomenOfKovsies

“I was determined to be more than just ‘the girl on crutches’; I wanted my brilliance to speak for itself,” said Mhluzi in response to the question, “What inspires you?”

As part of its #WomenOfKovsies campaign for 2019, which profiles inspiring women on our three campuses, the UFS celebrates LLB Law student, Esihle Mhluzi. She has served on a few SRC executive committees, UFS women empowerment organisations, and is also the Chairperson of the Universal Access Council for 2019.

Mhluzi says she was ‘graced’ with a physical impairment at the age of 10. She uses the word ‘grace’, because she appreciates what it means for the world and for women today to be in a body like hers. She also recently started pursuing a career in modelling, forming part of the top five of Miss Capable SA, and is currently one of the finalists for Face of Free State Fashion Week 2019.

Mhluzi explains that her decision to pursue modelling was propelled by her rationale to infiltrate spaces that were not necessarily designed for girls who ‘looked’ like her. She found that society seldom embraces and ‘accepts’ young women of her calibre on prestigious modelling platforms. Her mission is to ensure that she becomes the voice for the many women she represents. “With my additional modelling career path, I envisage us – women – running towards victory hand in hand,” said Mhluzi.

For her, being a woman means “being empty of yourself in order to create a better life for your fellow sister”. She believes a woman’s purpose is to extend grace and create safe spaces for each other to exist, heal, overcome, and conquer the world together, being in control of your narrative, and starving the noise. “Being a woman means having the audacity to be unapologetic in your brilliance,” she enthuses.

Mhluzi, who describes herself as ‘multifaceted’, believes that Women’s Month should be celebrated in order to pay homage to the phenomenal women who went before us. She highlights the importance of picking up where they left off. 

“I look forward to the day when being a woman simply means BEING.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept